Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
6   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

alvaro gonzalez cantero headshot

Álvaro

González-Cantero

,

MD, PhD

Consultant Dermatologist, Associate Professor
Hospital Ramón y Cajal University Hospital
Madrid
,
Spain
2021 Fellow
Councilor Since: January 1, 2023
IPC Councilor
Request an Update
Dr. Alvaro González-Cantero, MD, PhD, works as a dermatologist at the Department of Dermatology of the Ramón y Cajal University Hospital in Madrid, Spain, where he combines patient care with research. He received his PhD in psoriasis and comorbidities in 2019. He is the principal investigator for a cohort study investigating the pathophysiological mechanisms underlying cardiovascular comorbidity in psoriasis. Dr. González-Cantero has received independent and competitive research funding as principal investigator from the National Psoriasis Foundation (NPF) and the Spanish government. He has published extensively on the link between inflammation, atherosclerosis, and metabolic diseases in prestigious journals such as the Journal of Investigative Dermatology, Lancet, and the European Journal of Preventive Cardiology, among others. He has lectured on psoriasis at international meetings (AAD, EADV, SID). Dr. Gonzalez-Cantero has received numerous local and national awards and honors, including being named the best specialist in Spain. He is actively involved in several foundations and organizations in membership and leadership capacities, including the International Psoriasis Council (IPC), the Psoriasis Task Force of the EADV, and the National Psoriasis Foundation. He also serves as a reviewer for several international grant organizations and biomedical journals.
Last Updated:
11/04/2022

Areas of Interest

Psoriasis and comorbidities; the impact of psoriasis treatments on comorbidities; early intervention in psoriasis; psoriasis and lifestyle; mechanistic studies in psoriasis.

IPC Committees / Groups

Disease Severity Working Group

Languages Spoken

English, Spanish
Recent publications

Featured

Video

Molecular Mechanisms of Psoriasis Immunometabolism: A Comprehensive Overview.

IPC Councilor, Dr. Álvaro González-Cantero presents psoriasis as an immunometabolic disease, highlighting how immune…

Watch Video

PDF

A Report from the 2025 IPC Think Tank Symposium — Advancing Integrated Care: Psoriasis, Metabolic Health, and Future…

The 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…

View Report

PDF

Establishing Consensus on Defining Failure of Topical Therapy in Psoriasis: Recommendations from the International…

Early and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…

View Report

Blog

IPC Highlights from the IFPA Forum Americas in Bogotá.

The International Psoriasis Council (IPC) joined IFPA and regional leaders at the IFPA Forum Americas in Bogotá to…

Read More

Video

The Impact of Psoriasis Therapy on Cardiovascular Disease.

IPC Councilor Dr. Álvaro González-Cantero examines psoriasis as an independent risk factor for cardiovascular disease…

Watch Video

PDF

A Report from the 2025 American Academy of Dermatology (AAD) Annual Meeting.

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

View Report

Blog

Meet Our 2024 Volunteers of the Year.

The IPC's global network of experts volunteers annually to educate and train physicians, improving care for individuals…

Read More

Blog

Focus on Psoriasis: A Report from the 2024 American Academy of Dermatology (AAD) Annual Meeting.

The 2024 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 7 – Tuesday, March 12, 2024,…

Read More

Video

Impact of Obesity on Psoriasis.

Dr. Àlvaro González Cantero discusses the influence of obesity on psoriasis and provides solutions using treatment…

Watch Video

Video

International Panel: Cardiovascular Disease in the Clinic.

International panelists provide their expertise on cardiovascular disease and psoriasis.

Watch Video

Blog

Shining a Spotlight: Catching up with 2021 IPC Fellow Álvaro González-Cantero MD, PhD.

Catch up with 2021 IPC Fellow Professor Álvaro González-Cantero as he shares insights into his experience,…

Read More

Video

Cardiometabolic Comorbidities in Psoriasis: Bridging Evidence to Practice Gap.

Dr. Àlvaro González Cantero discusses the impact of cardiometabolic comorbidities on individuals with psoriasis and…

Watch Video

Event

Symposium: The Comprehensive Care of Psoriasis.

AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD) | SAN DIEGO, CALIFORNIA Thursday, March 7 14:00 - 18:00…

March 7, 2024
Learn More or Register

Event

IPC & AEDV Symposium: Tying Up Loose Ends in the Management of Psoriasis.

ACADEMIA ESPAÑOLA DE DERMATOLOGÍA Y VENEREOLOGÍA (AEDV) CONGRESS | MADRID, SPAIN Thursday, January 18 18:00 -…

January 18, 2024
Learn More or Register

Video

Statins and Psoriasis.

Dr. Álvaro González Cantero discusses using statins to prevent and improve activity in psoriasis patients with…

Watch Video

Video

Challenging Case 2: A Patient with Multiple Comorbidities.

Dr. González-Cantero presents a challenging case featuring a patient with multiple comorbidities.

Watch Video

Blog

Meet our Newest Councilors.

Introducing IPC’s newest Councilors for 2023: A cohort of global experts dedicated to improving patient care for…

Read More

Event

Symposium: Psoriasis: Using the Right Treatment in the Right Patient at the Right Time.

AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD) | NEW ORLEANS, LA Thursday, March 16 14:00 - 17:00…

March 16, 2023
Learn More or Register

Blog

Focus on Psoriasis: A Report from the European Academy of Dermatology and Venereology 31st Annual Congress (EADV).

The European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…

Read More

Blog

Focus on Psoriasis: A Report from the 2022 Society for Investigative Dermatology (SID) Annual Meeting.

The Society of Investigative Dermatology (SID) Annual Meeting returned to an in-person format in 2022 for the first…

Read More

What's New

When Your Patient with Psoriasis Is Diagnosed with Cancer

A patient doing well on an IL-17 inhibitor is diagnosed with cancer, and the oncologist wants the biologic stopped. It is a call most dermatologists have made without much to stand on: patients with cancer are excluded from psoriasis trials, so the entire evidence base is observational. A new IPC paper in JAAD Reviews takes a position anyway. Per the summary of product characteristics, active malignancy is not a contraindication to any biologic. IL-17 and IL-23p19 inhibitors are first-line, TNF inhibitors and deucravacitinib warrant caution, and cyclosporine is the one to avoid outright. The authors also warn that psoriasis severity is routinely underestimated once a patient is in oncology care: if they meet IPC’s criteria, they are a candidate for systemic therapy regardless of what else is on their problem list. “Too often, systemic psoriasis therapy is discontinued or never initiated in patients with cancer, even when the evidence supports safe and effective options,” says Paolo Gisondi, MD, IPC Councilor and lead author. The post includes the therapeutic options figure, designed as a reference for both specialties to work from, and a slide set for teaching and presentations.

READ NOW

Thursday, August 27, 2026

Apply Now: 2027 IPC International Fellowship Program

IPC is accepting applications for the 2027 International Fellowship Program, a 12-month opportunity for early-career dermatologists and researchers focused on psoriasis. Fellows are matched with IPC Board Members or Councilors for hands-on clinical or research experience, along with virtual mentoring, skills-development classes, and ongoing connections to IPC’s global network throughout the fellowship year. Applications are open until September 30, 2026.

APPLY NOW

Monday, August 31, 2026

IPC Generalized Pustular Psoriasis (GPP) Training Modules

Recognizing GPP in clinical practice can be a challenge, even for experienced dermatologists. IPC’s new five-part training series walks clinicians through the practical skills needed to diagnose and assess GPP with confidence: distinguishing it from plaque psoriasis and other mimicking conditions, and scoring its severity using tools such as the GPPGA and GPPASI. Each module pairs an expert-led video with a case-based exercise, and the series is built to be completed in sequence at your own pace. All five modules are free and open to everyone; watch the videos on your own or work through the assessments as you go. Score 80% or higher on each of the five assessments to earn a Certificate of Completion.

LEARN MORE

Thursday, August 13, 2026

IPC Summary Slides: Psoriasis and Metabolic Health

IPC has released a set of summary slides distilling the key findings from its recent publication on psoriasis and metabolic health, published in the Journal of the American Academy of Dermatology (JAAD). The paper outlines five priorities for improving cardiometabolic risk screening and care in patients with psoriasis. Designed for sharing, the slides give clinicians and colleagues an easy way to disseminate the findings.

LEARN MORE

Wednesday, August 5, 2026

Paradoxical Psoriasis - María Julia Cura, MD

In this Take Ten with IPC video, IPC Junior Councilor Dr. María Julia Cura discusses paradoxical psoriasis, including its definition and pathogenesis, and reviews clinical case examples, key clinical features, histopathology, predictors of disease severity, and potential treatment options.

WATCH NOW

Monday, August 3, 2026